NLS Pharmaceutics AG (NLSPW)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 21, 2025, 9:30 AM

0.00

0.00%

After-hours: Apr 21, 2025, 04:00 PM EDT

NLS Pharmaceutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q2 2017
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Jun 30, 2017
Net Income	-2.04M	-7.62M	-15.47M	-16.5M	-15.98M	-11.95M	-6.23M	-2.86M	-3.26M	-5.45M	-3.42M	-5.15K	-1.67M	-1.66M
Depreciation & Amortization	5.71K	5.71K	11.41K	11.41K	10.73K	10.05K	72.19M	72.19M	n/a	n/a	568.00	1.09K	522.41	n/a
Stock-Based Compensation	104.39	164.91	83.25	22.73	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	449.93K	-473.86K	320.27K	990.55K	1.1M	-875.26K	-1.62M	580.48K	866.67K	2.74M	2.29M	143.00	-2.53K	-2.44K
Other Non-Cash Items	101.02K	-681.66K	465.92K	364.64K	-1.94M	2.48M	2.42M	-1.42M	-840.24K	-237.96K	395.2K	1.22K	221.06K	221.1K
Deferred Income Tax	n/a	728.28K	568.27K	-160.01K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	400.68K	265.89K	911.44K	1.63M	3.08M	-3.17M	-3.87M	2.06M	1.77M	4.12M	3.01M	101.90	84.98K	85.07K
Operating Cash Flow	-1.53M	-7.3M	-13.51M	-13.88M	-12.87M	-14.94M	-9.93M	-729.39K	-1.44M	-190.01K	711.91K	-2.73K	-1.36M	-1.36M
Capital Expenditures	-2	n/a	n/a	n/a	-6.8K	-39.56K	-32.76K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	-7.6M	-3.52M	4.07M	-39.56K	99.52K	225.76K	1.1M	-217.47K	-1.22M	n/a	n/a	n/a
Debt Repayment	-194.72K	n/a	n/a	n/a	n/a	-1.43K	646.91K	1.19M	696.77K	154.89K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.63K	1.63K	13.81M	13.81M	3.55M	20.34M	16.21M	-686.7K	-362.53K	-259.7K	1.07K	557.92	819.17K	819.17K
Financial Cash Flow	1.19M	1.63K	13.81M	17.4M	7.14M	20.34M	16.85M	503.52K	334.24K	407.48K	513.36K	557.92	819.17K	819.17K
Net Cash Flow	551.11K	-6.4M	297.26K	3.52M	-5.74M	5.34M	6.95M	-126.56K	144.18K	220.27K	730.79	n/a	325.54K	325.04K
Free Cash Flow	-1.53M	-7.3M	-13.51M	-13.88M	-12.87M	-14.98M	-9.96M	-729.39K	-1.44M	-190.01K	711.91K	-2.73K	-1.36M	-1.36M